BFEC
CNMD icon

Benjamin F. Edwards & Company’s CONMED CNMD Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$14K Buy
207
+1
+0.5% +$73 ﹤0.01% 1625
2024
Q1 		$16K Sell
206
-3
-1% -$267 ﹤0.01% 1579
2023
Q4 		$23K Buy
+209
New +$21.6K ﹤0.01% 1452

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Benjamin F. Edwards & Company's CNMD Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its CONMED (CNMD) stake by 0.49% in Q2 2024, buying an estimated $73 and bringing the position to 207 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Benjamin F. Edwards & Company first reported a position in CNMD in Q4 2023 and has held it in 3 quarters since. The position peaked at $23K in Q4 2023. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Benjamin F. Edwards & Company held 207 shares of CONMED worth $14K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 1 CONMED share in Q2 2024, an estimated $73.
  • CONMED made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1625 holding.
  • Benjamin F. Edwards & Company first reported a position in CONMED in Q4 2023 and has held it in 3 quarters since.
  • Benjamin F. Edwards & Company's CONMED position peaked at $23K in Q4 2023.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.